Hemoadsorption in cardiac shock with bi ventricular failure and giant-cell myocarditis: A case report
Authors:
- 30 May 2018
- journal article
- research article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 41 (8) , 474-479
Abstract
Purpose: Giant-cell myocarditis represents a rare and often fatal autoimmune disorder. Despite extracorporeal life support being a valid treatment option, alternatives to control the underlying inflammatory response remain sparse. A new hemoadsorption device (CytoSorb) has recently been introduced to treat patients with an excessive inflammatory response. Methods: A 57-year-old patient developed fulminant right heart failure, respiratory insufficiency, hemodynamic instability, and oliguric–anuric renal failure. An extracorporeal life support together with an Impella was implanted for circulatory support. Due to non-pulsatility, acontractility of the left ventricle and a heavily reduced right ventricular function, a left ventricular assist device implantation and change from extracorporeal life support to veno-pulmonary arterial extracorporeal membrane oxygenation was performed. Since adequate hemodynamic stabilization could not be achieved and due to increasing inflammatory mediators and bilirubin levels, the decision was made to additionally integrate a CytoSorb hemoadsorber into the system. Results: The combined treatment resulted in a clear and steady improvement in hemodynamics and the inflammatory condition with marked reductions in all measured parameters throughout the treatment period. Metabolic acidosis resolved and liver function improved. Conclusion: Extracorporeal life support therapy represents a bridging approach to heart transplantation or to cardiac recovery and can be complemented by CytoSorb as an independent therapeutic option. The patient described herein with giant-cell myocarditis and fulminant cardiac failure who received substantial extracorporeal support in combination with CytoSorb hemoadsorption therapy benefited in terms of an improvement of organ function and his inflammatory situation.Keywords
This publication has 19 references indexed in Scilit:
- Lidocaine can reduce the pain of intra-osseous fluid infusionCritical Care, 2016
- Treatment of Post-Cardiopulmonary Bypass SIRS by Hemoadsorption: A Case SeriesThe International Journal of Artificial Organs, 2016
- Pathogenesis of Arrhythmogenic CardiomyopathyCanadian Journal of Cardiology, 2015
- Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat modelCritical Care, 2014
- Effect of cytokine hemoadsorption on brain death–induced ventricular dysfunction in a porcine modelThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Giant cell myocarditisHerz, 2012
- Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress responseFree Radical Biology and Medicine, 2011
- A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditisJACC, 2003
- Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcomeThe Journal of Heart and Lung Transplantation, 2002
- Idiopathic Giant-Cell Myocarditis — Natural History and TreatmentNew England Journal of Medicine, 1997